The Purpose of This Study is to Determine the Frequency of Colorectal Cancer in Male and Female Endurance Athletes Between the Ages of 35 and 50

Last updated: November 25, 2024
Sponsor: Inova Health Care Services
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Rectal Cancer

Colon Cancer

Colon Cancer; Rectal Cancer

Treatment

prospective observational study - screening and follow up colonoscopy

Clinical Study ID

NCT05419531
U21-10-4567
  • Ages 35-50
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to determine the frequency of colorectal cancer in male and female endurance athletes between the ages of 35 and 50.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adult males and females 35-50 years of age

  • Male and female self-reported endurance athletes, defined by at least one of thefollowing:

  • Run at least two races of 50 miles or more

  • Run 5 races of 26.2 miles or more

  • Ability to complete testing in the protocol and make study visits

  • Able and willing to consent to protocol

Exclusion

Exclusion Criteria:

  • Known or suspected history of inflammatory bowel disease, familial adenomatouspolyposis (FAP), or Lynch Syndrome

  • Concomitant illness that would prevent adequate patient assessment or in theinvestigators' opinion pose an added risk for study participants.

  • Anticipated poor compliance

  • Prisoners or subjects who are involuntarily incarcerated

  • Persons with decisional incapacity/cognitive impairment

  • Any history or evidence of severe illness or any other condition that would make thepatient, in the opinion of the investigator unsuitable for the study

  • Subject is involved with a worker's compensation, personal injury, or other legalmatters related to their health

  • Subject is enrolled in a separate interventional clinical trial

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: prospective observational study - screening and follow up colonoscopy
Phase:
Study Start date:
October 18, 2022
Estimated Completion Date:
August 31, 2025

Connect with a study center

  • Inova Schar Cancer Institute

    Fairfax, Virginia 22031
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.